TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia

Published:2024-01-25 Issue:4 Volume:119 Page:450-458
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Ueki Hideaki,Ogawa Chitose,Goto Hiroaki,Nishi Masanori,Yamanaka Junko,Mochizuki Shinji,Nishikawa Takuro,Kumamoto Tadashi,Nishiuchi Ritsuo,Kikuta Atsushi,Yamamoto Shohei,Igarashi Shunji,Sato Atsushi,Hori Toshinori,Saito Akiko M.,Watanabe Tomoyuki,Deguchi Takao,Manabe Atsushi,Horibe Keizo,Toyoda Hidemi^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12185-024-03710-6.pdf

Reference23 articles.

1. Eckert C, Groeneveld-Krentz S, Kirschner-Schwabe R, Hagedorn N, Chen-Santel C, Bader P, et al. Improving stratification for children with late bone marrow B-cell acute lymphoblastic leukemia relapses with refined response classification and integration of genetics. J Clin Oncol. 2019;37(36):3493–506.

2. Lew G, Chen Y, Lu X, Rheingold SR, Whitlock JA, Devidas M, et al. Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children’s Oncology Group phase III study AALL0433. Haematologica. 2021;106(1):46–55.

3. Eckert C, Henze G, Seeger K, Hagedorn N, Mann G, Panzer-Grümayer R, et al. Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group. J Clin Oncol. 2013;31(21):2736–42.

4. Badell I, Muñoz A, Ortega JJ, Martínez A, Madero L, Bureo E, et al. Long-term outcome of allogeneic or autologous haemopoietic cell transplantation for acute lymphoblastic leukaemia in second remission in children. GETMON experience 1983–1998. Bone Marrow Transplant. 2005;35(9):895–901.

5. Dopfer R, Henze G, Bender-Götze C, Ebell W, Ehninger G, Friedrich W, et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. Blood. 1991;78(10):2780–4.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes in children with first‐relapsed acute lymphoblastic leukemia in Japan: Results from JCCG Study JPLSG‐ALL‐R08;Pediatric Blood & Cancer;2024-09-12